openPR Logo
Press release

Home Infusion Therapy Market Surges Towards US$ 83.02 Billion by 2034

04-03-2024 08:33 PM CET | Health & Medicine

Press release from: Fact.MR

Home Infusion Therapy Market

Home Infusion Therapy Market

The global Home Infusion Therapy Market is expected to experience significant growth, reaching a value of US$ 83.02 billion by the end of 2034, up from US$ 36.29 billion in 2024. According to the latest research report by Fact.MR, the market is projected to grow at a compound annual growth rate (CAGR) of 8.6% during the period from 2024 to 2034. Several factors contribute to this growth trajectory. Firstly, there is a rising preference for home care healthcare facilities, driven by the convenience and comfort they offer to patients. Additionally, ongoing technological advancements in the medical field contribute to the expansion of home infusion therapy services. The growing population of elderly individuals with mobility issues also plays a significant role in driving market growth.

๐—š๐—ฒ๐˜ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐—ฝ๐˜†:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7169

Home infusion therapy encompasses various essential components such as IV hydration therapy and IV therapy, which are crucial for providing effective treatment to patients. The increasing demand for these therapies is largely driven by the need for long-term treatment among many patients. Furthermore, there is a growing trend towards home infusion therapy as a cost-effective alternative to hospital care, providing patients with personalized medical solutions while allowing them to remain in the comfort of their own homes.

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐˜€:

Convenience and Comfort: One of the primary drivers of the home infusion therapy industry is the convenience and comfort it offers to patients. Instead of frequent hospital visits, patients can receive treatments at home, reducing the hassle and stress associated with traveling to medical facilities.

Cost-Efficiency: Home infusion therapy can be more cost-effective compared to traditional hospital-based treatments. By receiving care at home, patients can avoid expenses related to hospital stays, such as room charges and additional fees, making it a more affordable option for many individuals and healthcare systems.
Advancements in Technology: Technological advancements have played a crucial role in the growth of the home infusion therapy industry. The development of specialized medical devices and equipment has made it easier and safer for patients to administer medications at home, under the guidance of trained healthcare professionals.

Rising Chronic Disease Cases: The increasing prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has contributed to the demand for home infusion therapy services. These conditions often require long-term treatment regimens, making home-based care a practical and preferred option for many patients.

Aging Population: With the aging population globally, there is a growing need for healthcare services that cater to older adults. Home infusion therapy allows elderly patients to receive necessary treatments without the inconvenience of frequent hospital visits, promoting independence and improving overall quality of life.
๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ข๐˜‚๐˜๐—น๐—ผ๐—ผ๐—ธ:

Expansion of Services: As the demand for home infusion therapy continues to rise, we can expect to see an expansion of services offered in this sector. This may include a wider range of medications and treatments available for administration at home, catering to diverse patient needs.

Integration of Telehealth: Telehealth technology is expected to play a significant role in the future of home infusion therapy. Through virtual consultations and remote monitoring, healthcare providers can closely monitor patients' progress and adjust treatment plans as needed, enhancing the overall efficiency and effectiveness of home-based care.

Regulatory Advancements: Regulatory agencies are likely to implement policies and guidelines to ensure the safety and quality of home infusion therapy services. Stricter regulations and standards may be introduced to govern the training of healthcare professionals involved in home-based care and the handling of medications and equipment.

Collaboration with Healthcare Providers: Collaboration between home infusion therapy providers and other healthcare stakeholders, such as hospitals, clinics, and pharmaceutical companies, will be essential for driving innovation and improving patient outcomes. By working together, these entities can streamline processes, share resources, and deliver integrated care solutions to patients.

Patient-Centric Approach: With a growing emphasis on patient-centered care, the home infusion therapy industry is likely to prioritize personalized treatment plans tailored to individual patient needs and preferences. This approach aims to empower patients in managing their health and promoting better adherence to treatment regimens.

๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜ ๐—™๐—ผ๐—ฟ ๐—™๐—ฅ๐—˜๐—˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7169

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€:

CVS/Coram
JMS Co. Ltd.
BD
Option Care Health
Terumo Corporation
BriovaRx/Diplomat
PharMerica
Smiths Medical
Baxter
Fresenius Kabi
Caesarea Medical Electronics
ICU Medical, Inc.
Braun Melsungen AG

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ:

The increasing utilization of healthcare technologies to enhance healthcare services in home environments is expected to create lucrative opportunities for industry participants. As a result, companies are implementing various strategies including mergers, acquisitions, new product development, quality control measures, and providing high-quality products to end users in order to gain a competitive advantage.

For example:

In May 2021, Ivenix, Inc. and Smiths Medical formed a partnership aimed at offering a comprehensive range of infusion management solutions in the United States. This collaboration is intended to improve patient and administrative safety.

PromptCare, in March 2021, acquired NBN Infusions, Inc., a New Jersey-based provider of respiratory therapy and home infusion services. NBN Infusions specializes in delivering infusion therapy to patients with critical medical conditions.Top of Form

๐—•๐—ฟ๐—ผ๐˜„๐˜€๐—ฒ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ @ https://www.factmr.com/report/home-infusion-therapy-market

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

โ€ข By Product Type :
o Infusion Pumps
o Intravenous Sets
o IV Cannulas
o Needleless Connectors

โ€ข By Application :
o Anti-infective
o Endocrinology
o Hydration Therapy
o Chemotherapy
o Enteral Nutrition
o Parenteral Nutrition
o Specialty Pharmaceuticals

โ€ข By Region :
o North America
o Europe
o East Asia
o Latin America
o Middle East & Africa
o South Asia & Oceania

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Home Infusion Therapy Market Surges Towards US$ 83.02 Billion by 2034 here

News-ID: 3451157 • Views: โ€ฆ

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA โ€ฆ
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % betweenโ€ฆ
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; โ€ฆ
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand forโ€ฆ
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva โ€ฆ
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Keyโ€ฆ
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico โ€ฆ
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rateโ€ฆ

All 5 Releases


More Releases for Infusion

Elastomeric Infusion Pumps Market 2024: Innovations in Portable Medical Infusion โ€ฆ
"The Business Research Company recently released a comprehensive report on the Global Elastomeric Infusion Pumps Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The elastomeric infusion pumpsโ€ฆ
Drug Infusion Systems Market Delivering Precision Care: The Booming Drug Infusio โ€ฆ
Drug Infusion Systems Market Assessment worth $ 23.27 Billion by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug Infusion Systems Market- by Product (Large Volume Infusion Systems, Patient-Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems and Enteral Infusion Systems), Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics andโ€ฆ
Infusion Services Market - Better Time Ahead| ARJ Infusion Services, Accredo Hea โ€ฆ
According to HTF Market Intelligence, the Global Infusion Services market to witness a CAGR of 5.34% during the forecast period (2023-2029). The Latest Released Infusion Services Market Research assesses the future growth potential of the Infusion Services market and provides information and useful statistics on market structure and size. This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps andโ€ฆ
Analgesic Infusion Pumps Market - Enhancing patient comfort through advanced ana โ€ฆ
Newark, New Castle, USA: The "Analgesic Infusion Pumps Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Analgesic Infusion Pumps Market: https://www.growthplusreports.com/report/analgesic-infusion-pumps-market/7817 This latest report researches the industry structure,โ€ฆ
Infusion Pump Market - Transforming Healthcare Delivery: Infusion Pumps Driving โ€ฆ
Newark, New Castle, USA - new report, titled Infusion Pump Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Infusion Pump market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Infusion Pump market. The report offers an overview of the market, whichโ€ฆ
Intravenous Infusion Pump Market by Type (Volumetric Infusion Pumps, Syringe Inf โ€ฆ
Report Overview The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2023 to 2032. An intravenous infusion pump is a medical tool used to administer drugs or nutrients directly into a patient's bloodstream. These are frequently seen in medical facilities since they are frequently utilised to transport drugs in precise quantities. Theโ€ฆ